- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04673331
Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic
Comparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation in the COVID-19 Pandemic
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being over 18 years old Having the ability to access the internet through a device (computer or mobile device) that enables video conferencing Giving consent on a voluntary basis
Exclusion Criteria:
- Severe comorbidity that limits mobilization or physical activity(orthopedic, cardiac or neurological condition) Pregnancy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cystic fibrosis
Inclusion Criteria: Having been diagnosed with cystic fibrosis Being over 18 years old The clinical condition is stable Having the ability to access the internet through a device (computer or mobile device) that enables video conferencing Giving consent on a voluntary basis Exclusion Criteria: Severe comorbidity that limits mobilization or physical activity(orthopedic, cardiac or neurological condition) Pregnancy |
3minute step test and 1minute sit to stand test used assessment of exercise capacity.
|
Healthy individuals
Inclusion Criteria: Being over 18 years old Having the ability to access the internet through a device (computer or mobile device) that enables video conferencing Giving consent on a voluntary basis Exclusion Criteria: Severe comorbidity that limits mobilization or physical activity(orthopedic, cardiac or neurological condition) Pregnancy |
3minute step test and 1minute sit to stand test used assessment of exercise capacity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity Level-International Physical Activity Questionnaire
Time Frame: 8 minutes
|
Physical activity level will be evaluated International Physical Activity Questionnaire- Short Form (IPAQ-SF).
IPAQ short version asks spended time during sitting, walking, moderate and vigorous physical activities.
The score is obtained by multiplying the minutes, days and metabolic equivalent values.
According to these scores, physical activity levels are classified as "inactive", "minimally active" and "very active".
|
8 minutes
|
Coronavirus Phobia-Coronavirus-19 Phobia Scale
Time Frame: 5 minutes
|
COVID-19 phobia will be evaluated with Coronavirus-19 Phobia Scale (C19P-S) and total score ranges from 20-100.
Lower scores mean better outcome.
|
5 minutes
|
Exercise Capacity
Time Frame: 15 minutes
|
Exercise capacity will be evaluated with 1-minute sit to stand test and 3-minute step test.
Maximum heart rate, minimum saturation, count of step are record during the 3 minute step test.
Number of sit to stand for 1 minute is recorded end of the 1 minute sit to stand test.
|
15 minutes
|
Weekly Average Steps
Time Frame: 2 minutes
|
The number of steps in the last week was recorded and averaged using the pedometer applications from the participants own smartphones. <5000 steps/day sedentary 5000-7499 steps/day low active 7500-9999 steps/day somewhat active ≥10 000 steps/day active >12 500 steps/day highly active |
2 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive Function-Standardized Mini Mental State Examination
Time Frame: 5 minutes
|
Cognitive function evaluation will be Standardized Mini Mental State Examination (SMMSE).
Scores less than 23 mean cognitive impairment.
|
5 minutes
|
Quality Of Life-Nottingham Health Profile
Time Frame: 10 minutes
|
Quality of life will be evaluated with Nottingham Health Profile (NHP).
This questionnaire categorizes are energy, pain, emotional reactions, sleep, social isolation, physical mobility, depression and anxiety.
Lower scores mean better outcome.
|
10 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Naciye Vardar Yağlı, PhD, Hacettepe University
- Principal Investigator: Aydan Aslı Aksel, Hacettepe University
- Study Chair: Ebru Damadoğlu, PhD, Hacettepe University
- Study Chair: Merve Fırat, MSc, Hacettepe University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Infant, Newborn, Diseases
- Genetic Diseases, Inborn
- Pancreatic Diseases
- Fibrosis
- COVID-19
- Cystic Fibrosis
Other Study ID Numbers
- GO 20/794
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
-
Arrowhead PharmaceuticalsTerminatedCystic Fibrosis, PulmonaryAustralia, New Zealand
-
AzurRx SASCompletedCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of PancreasTurkey, Hungary
-
Dartmouth-Hitchcock Medical CenterTrustees of Dartmouth CollegeWithdrawnCystic Fibrosis-related Diabetes | Cystic Fibrosis Liver Disease | CF - Cystic FibrosisUnited States
-
University Hospital, BordeauxCompleted
-
University of PortsmouthUniversity Hospital Southampton NHS Foundation Trust; Loughborough University; Queen Alexandra HospitalTerminated
Clinical Trials on exercise capacity
-
Hacettepe UniversityCompletedSurvivorship | Lung NeoplasmTurkey
-
Hacettepe UniversityCompletedMucopolysaccharidosesTurkey
-
Goksen Kuran AslanCompleted
-
Hacettepe UniversityCompletedHealthy | Obesity, ChildhoodTurkey
-
University of ZurichCompletedHigh Altitude Pulmonary Hypertension | Maximal Exercise CapacitySwitzerland
-
National Taiwan University HospitalCompletedDiabetes Mellitus, Type 2Taiwan
-
Hacettepe UniversityCompletedMultiple SclerosisTurkey
-
Hacettepe UniversityCompletedSingle-ventricle | Exercise Capacity | Hemodynamic Instability | Arterial Stiffness | Muscle Oxygenation | Fontan ProcedureTurkey
-
Hacettepe UniversityCompletedInflammation | Diabetes Mellitus, Type 2 | Prediabetic State | Cardiorespiratory Fitness | Exercise TestTurkey
-
The Opole University of TechnologyCompleted